Abstract. The prostaglandin (PG) analogue 7-oxa-13\x=req-\ prostynoic acid 
its potentiating effect on PGE2-induced LH release 7 \ x =r e q -\ OPA did not alter the stimulatory action of PGF2\g=a\(2 \ g=m\ g) on the secretion of LH. 7-OPA had no effect on LRH\x=req-\ induced release of LH indicating that the PG analogue acts at a suprapituitary site to enhance PGE2-induced LH release. The potentiating effect of 7-OPA may be exerted at a binding site for PGE2 in the brain and the results suggest the existence of a different binding site for PGF2\g=a\.The possibility also exists that 7-OPA inhibit metabolic inactivation of PGE2.
A substantial amount of evidence indicates that prostaglandins (PGs) are involved in the neural regulation of pituitary gonadotrophin secretion (Hedge 1977) . The primary site of action appears to be in the hypothalamus (Harms et al. 1974; Eskay et al. 1975 Eskay et al. , 1977 Chobsieng et al. 1975; Drouin et al. 1976) (Schaumburg 1973) , lipocytes (Kuehl & Humes 1972) , and corpus luteum (Powell et al. 1974 (Powell et al. , 1975 , and it has recently been sug¬ gested (Warberg et al. 1976 ) that PGs might also bind to a receptor site in the brain as an event prior to their stimulatory effect on the release of LRH and LH. This hypothesis was based on the observa¬ tion that PGs with certain functional groups (pre¬ viously found to be important for receptor activa¬ tion) (Powell et al. 1974 (Powell et al. , 1975 
Materials and Methods
Adult male rats of the Wistar strain (350-400 g, bred at the Panum Institute) were anaesthetized with pentobarbital injected ip (6-8 mg/100 g body weight). The animals were ventilated with oxygen through an endotracheal tube connected to a rodent respirator. intraventricularly before the administration of 2 pg PGE2 the stimulatory effect of PGE2 was poten¬ tiated almost equally by the two doses of 7-OPA ( Fig. 1) . At 90 min the LH concentration of animals primed with 88 or 132 pg 7-OPA was significantly higher (P < 0.02 and P < 0.01, respectively) than that of control rats which received the 7-OPA vehicle. When 44 pg of 7-OPA was infused the LH concentration observed during the 60-90 min period was higher than that found at a correspond¬ ing time in the control animals but the difference was not significant (P > 0.05). However, at all doses of 7-OPA administered, the LH concentra¬ tion in plasma continued to increase throughout the experimental period. This pattern of LH secre¬ tion was in contrast to that observed in the control animals where the LH concentration came to a level at 60 min. 7-OPA alone had no effect on LH secretion as seen when the analogue was infused intraventricularly followed by infusion of the di¬ luent for PGE2 (Fig. 1) (Fig. 4) . By 90 min the LH concentration was 4 -5-fold greater than the pre-infusion level.
Administration of 132 pg 7-OPA had no effect on PGF2a-induced LH release.
Effect of lateral ventricle infusion of 7-OPA on LRH-induced LH release When 132 pg of 7-OPA was infused into a lateral ventricle prior to intraventricular infusion of 50 ng of LRH it was found that the time course of LH release and the amount of hormone secreted were identical to that observed in control experiments where LRH was administered without 7-OPA priming (Fig. 5) .
Discussion
The results of this investigation show that the PG analogue 7-OPA potentiates the stimulatory action of PGE2 on LH secretion in vivo. Furthermore, 7-OPA caused a formerly sub-threshold dose of PGE2 to become an effective stimulus for LH release. In addition, it was found that the minimal amount of PGE2 necessary for the stimulation of LH release in male rats was within the dose range 0.01-0.05 pg. These threshold values have not previously been reported.
The present observations are somewhat surpris¬ ing because it has earlier been found that 7-OPA has an inhibitory effect on stimulus-induced re¬ lease of anterior pituitary hormones in vitro (Vale et al. 1971; Ratner et al. 1973; Dowd et al. 1973 ).
Since 7-OPA is considered to be a competitive PG-antagonist presumably acting at the receptor level (Fried et al. 1969 (Fried et al. , 1971 Kuehl & Humes 1972; Eakins & Sanner 1972) (Powell et al. 1974 (Powell et al. , 1975 . It was suggested that activation of a PG binding site in the brain was essential for PG-induced release of LH (Warberg et al. 1976 ). Since PGE2 stimulates the secretion of LH pri¬ marily via enhanced release of LRH from the brain (Harms et al. 1974; Eskay et al. 1975 Eskay et al. , 1977 Chobsieng et al. 1975; Drouin et al. 1976 In addition to interfering with the binding of PGs 7-OPA also inhibits their synthesis (Fried et al. 1971 ). However, it appears unlikely that the pre¬ sent findings are attributable to this action of the analogue since blockade of PG synthesis in the brain has been reported to inhibit (and not stimu¬ late) LH release in the rat (Ojeda et al. 1975 
